PubMed · 1444085
Endothelin does not affect experimentally induced corneal neovascularization.
Abstract
Endothelin, a potent vasoconstrictor, was found to be ineffective in the treatment of experimentally induced corneal neovascularization. Endothelin was administered topically, subconjunctivally, and intraluminally in serial concentrations ranging from 0.0005 to 5.0 micrograms/mL in New Zealand white rabbits without effect. Electron microscopy of the neovascular cornea revealed the vessels consisted only of endothelin and pericytes. Hence, the vessels were not responsive to endothelin because they lacked contractile smooth muscle.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
R A Eiferman, J Stagner, M Jumblatt, K P O'Neill, D A Smith. 1992. Endothelin does not affect experimentally induced corneal neovascularization.. https://pubmed.ncbi.nlm.nih.gov/1444085/
Cite the original work for its findings. Save a collection to share your selection of sources.